Dr.  

April Armstrong


Presentations

Consistency of Response by age in Patients With Moderate-to-Severe Psoriasis Treated With Guselkumab vs. Secukinumab: Week 48 Results From the ECLIPSE Study Trial 09 October 2019 00:00 - 00:00
Guselkumab Demonstrates Greater Efficacy Compared to Secukinumab Across Body Weight Quartiles and Body Mass Index Categories: Week 48 Results From the ECLIPSE Trial 09 October 2019 00:00 - 00:00

Abstracts

Consistency of Response by age in Patients With Moderate-to-Severe Psoriasis Treated With Guselkumab vs. Secukinumab: Week 48 Results From the ECLIPSE Study Trial Psoriasis More
Guselkumab Demonstrates Greater Efficacy Compared to Secukinumab Across Body Weight Quartiles and Body Mass Index Categories: Week 48 Results From the ECLIPSE Trial Psoriasis More